Table 1. Baseline Demographic and Clinical Characteristics of Patients.
| Characteristic | ITB (n=37) | CD (n=43) | IBS (n=18) |
P-value ITB vs. CD vs. IBS |
|---|---|---|---|---|
| Age (yr) | 31.0 (24.00–42.50) | 32.0 (23.00–40.00) | 30.5 (22.00–41.25) | 0.96 |
| Sex (male:female) | 18:19 | 29:14 | 15:3 | 0.03 |
| Hemoglobin (g/dL) | 11.3 (10.4–12.6) | 11.8 (9.7–13.2) | 13.4 (11.4–15.0) | 0.02 |
| Serum albumin (g/dL) | 4.3 (4.0–4.8) | 4.0 (3.6–4.6) | 4.2 (3.9–5.0) | 0.22 |
| Montreal classification | ||||
| Locationa | ||||
| L1 | 15 (40.5) | 17 (39.5) | ||
| L2 | 12 (32.4) | 11 (25.5) | ||
| L3 | 8 (21.6) | 13 (30.2) | ||
| L4 | 8 (21.6) | 3 (6.9) | ||
| Behavior | ||||
| B1 | 28 (75.6) | 30 (69.7) | ||
| B2 | 9 (24.3) | 13 (30.2) | ||
| B3 | 0 | 0 | ||
| P | 0 | 0 | ||
| History of prior antituberculosis therapy | 5 (13.5) | 18 (41.8) | ||
| Duration of follow-up (mo) | 7 (6.0–9.0) | 7 (4.0–9.5) | ||
| Duration of disease (mo) | 14 (6.0–24.0) | 12 (6.0–36.0) |
Values are presented as median (IQR) or number (%).
aIn the intestinal tuberculosis (ITB) group, three patients had both upper gastrointestinal (UGI) and distal ileal involvement, two had both UGI and colonic involvement, and one had both UGI and ileocolonic involvement.
P, perianal disease modifier.